Gritstone bio, Inc.
GRTS · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $1 | $9 | $47 | $4 |
| % Growth | -85.6% | -80.2% | 1,057.2% | – |
| Cost of Goods Sold | $8 | $16 | $14 | $89 |
| Gross Profit | -$6 | -$6 | $32 | -$85 |
| % Margin | -470.3% | -69.3% | 69.2% | -2,095.8% |
| R&D Expenses | $127 | $111 | $97 | $89 |
| G&A Expenses | $29 | $29 | $26 | $21 |
| SG&A Expenses | $21 | $29 | $26 | $21 |
| Sales & Mktg Exp. | -$8 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$11 | -$1 | $0 |
| Operating Expenses | $148 | $130 | $122 | $110 |
| Operating Income | -$155 | -$120 | -$75 | -$106 |
| % Margin | -11,617.9% | -1,299.3% | -161% | -2,626.1% |
| Other Income/Exp. Net | $1 | $1 | $0 | $1 |
| Pre-Tax Income | -$138 | -$120 | -$75 | -$105 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$138 | -$113 | -$75 | -$105 |
| % Margin | -10,405% | -1,220.5% | -160.4% | -2,591.3% |
| EPS | -1.2 | -1.24 | -0.95 | -2.77 |
| % Growth | 3.2% | -30.5% | 65.7% | – |
| EPS Diluted | -1.2 | -1.24 | -0.95 | -2.77 |
| Weighted Avg Shares Out | 116 | 91 | 79 | 38 |
| Weighted Avg Shares Out Dil | 116 | 91 | 79 | 38 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $2 | $0 | $1 |
| Interest Expense | $4 | $1 | $0 | $0 |
| Depreciation & Amortization | $8 | $16 | $14 | $7 |
| EBITDA | -$127 | -$112 | -$69 | -$99 |
| % Margin | -9,531.4% | -1,207.2% | -147.1% | -2,444.1% |